Perspective: interesterified triglycerides, the recent increase in deaths from heart disease, and elevated blood viscosity

Ther Adv Cardiovasc Dis. 2018 Jan;12(1):23-28. doi: 10.1177/1753944717745507.

Abstract

The authors hypothesize that consumption of interesterified fats may be the cause of the continuous increase in cardiovascular deaths in the United States which began in 2011. Interesterification is a method of producing solid fats from vegetable oil and began to supplant partial hydrogenation for this purpose upon recognition of the danger of trans fats to cardiovascular health. Long, straight carbon chains, as are present in saturated and trans fatty acids, decrease the fluidity of the erythrocyte cell membrane, which decreases erythrocyte deformability and increases blood viscosity. This decrease in cell membrane fluidity is caused by increased van der Waals interactions, which also solidify dietary fats. Elevated blood viscosity is favored as the pathogenic mechanism by which trans fats increase cardiovascular mortality because changes in lipoprotein levels do not account for all the mortality attributable to their consumption. The rapid changes in cardiovascular mortality noted with the introduction and withdrawal of trans fats from the food supply are reviewed. The evidence implicating elevated blood viscosity in cardiovascular disease is also reviewed. Data regarding the production and consumption of interesterified fats in the US should be released in order to determine if there is an association with the observed increase in cardiovascular deaths.

Keywords: blood; deformability; erythrocyte; interesterification; lipids; trans; triglycerides; viscosity.

Publication types

  • Review

MeSH terms

  • Animals
  • Blood Viscosity*
  • Dietary Fats / adverse effects*
  • Dietary Fats / blood
  • Erythrocyte Membrane / drug effects*
  • Erythrocyte Membrane / metabolism
  • Esterification
  • Heart Failure / blood
  • Heart Failure / diagnosis
  • Heart Failure / mortality*
  • Humans
  • Membrane Fluidity / drug effects
  • Prognosis
  • Risk Assessment
  • Risk Factors
  • Thrombosis / blood
  • Thrombosis / diagnosis
  • Thrombosis / mortality*
  • Time Factors
  • Trans Fatty Acids / adverse effects
  • Triglycerides / adverse effects*
  • Triglycerides / blood

Substances

  • Dietary Fats
  • Trans Fatty Acids
  • Triglycerides